Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> ActivityThomas H. Pillow, Peter S. Dragovich, Katherine R. Kozak et al.|ChemMedChem|2019Cited by 193
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor EfficacyPeter S. Dragovich, Xiaoyu Zhu, Thomas H. Pillow et al.|Journal of Medicinal Chemistry|2021Cited by 168
Disruption of IRE1α through its kinase domain attenuates multiple myelomaAvi Ashkenazi, Adrien Le Thomas, Anna Shemorry et al.|Proceedings of the National Academy of Sciences|2019Cited by 115
Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitorsAaron Smith, Cynthia M. Shafer, Zhi‐Jie Ni et al.|Bioorganic & Medicinal Chemistry Letters|2017Cited by 8
Abstract 20: Raf kinase inhibitors can induce Raf dimerization, downstream signaling, and cell growthTobi Nagel, Darrin D. Stuart, Kevin Shoemaker et al.|Cancer Research|2010Cited by 2